– Second quarter cash provided by operations of $460 million, up 30.1% from 2020 – Second quarter reported diluted earnings per share (“EPS”) of $4.96, up 264.2% from 2020; and adjusted diluted EPS of $3.18, up 123.9% from 2020
SECAUCUS, N.J., July 22, 2021 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2021.
– Establishes full year 2021 outlook
Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)
“We had another strong quarter, with a faster than expected recovery in our base business,” said Steve Rusckowski, Chairman, CEO and President. “This was the first quarter since 2019 that organic base testing revenues grew in the quarter, driven by contributions from new hospital lab management contracts as well as people returning to the healthcare system. We are well-positioned to continue our momentum and support the return to health care in the coming months, which is reflected in the outlook we have provided for the remainder of 2021.”
Three Months Ended June 30,
Six Months Ended June 30,
(dollars in millions, except per share data)
News Highlights Business
- Quest Diagnostics Reports Second Quarter 2021 Financial Results; Sets outlook for the entire year 2021
- Check all news and articles from the Business news updates.